跳至主要内容
临床试验/NCT00801333
NCT00801333招募中不适用

Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells

Hadassah Medical Organization2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2008年11月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
25
试验地点
2

研究概览

简要总结

Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation.

The major goal of the project is to develop human iPS cells from various types of cell cultures or lines from existing collections. The IPS cells will be developed for modeling diseases, for developing the technology that may eventually allow the use of IPS cells for transplantation therapy, and for basic research.

详细描述

The potential to reprogram somatic cells into an embryonic state raises multiple basic research questions related both to the process of reprogramming and the properties of iPS cells. We will use various approaches to study the molecular mechanisms and processes that occur during reprogramming. We will use various experimental systems to characterize and study the properties of the iPS cells, their biology, developmental potential, capability to give rise to functional differentiated progeny etc.

We will induce the differentiation of the iPS cells towards specific cell lineages and the progeny can be used to study the pathogenesis of diseases. They will be used for developing new therapeutic approaches and for high throughput screening of factors for potential toxic or therapeutic effects.

All samples will be non-identified.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Volunteers
  • Male and Female

排除标准

  • Below the official age of consent

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Benjamin Reubinoff

Professor

Hadassah Medical Organization

研究点 (2)

Loading locations...

相似试验